Imed Infinity Medical-Limited Partnership (TLV:IMED)
Israel · Delayed Price · Currency is ILS · Price in ILA 113.00
+0.70 (0.62%)
At close: Mar 5, 2026
TLV:IMED Market Cap
TLV:IMED has a market cap or net worth of 4.56 million as of March 13, 2026. Its market cap has increased by 22.29% in one year.
Market Cap
4.56M
Enterprise Value
-8.63M
Revenue
2.76M
Ranking
n/a
PE Ratio
4.94
Stock Price
113.00
Market Cap Chart
Since December 29, 2020, TLV:IMED's market cap has decreased from 40.32M to 4.56M, a decrease of -88.69%. That is a compound annual growth rate of -34.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 4.56M | -7.30% |
| Dec 31, 2025 | 4.92M | 9.43% |
| Dec 30, 2024 | 4.49M | -2.45% |
| Dec 31, 2023 | 4.61M | -19.63% |
| Dec 27, 2022 | 5.73M | -55.66% |
| Dec 30, 2021 | 12.93M | -67.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 106.89B |
| Danel (Adir Yeoshua) | 2.60B |
| BrainsWay | 1.64B |
| Kamada | 1.58B |
| Evogene | 22.34M |
| XTL Biopharmaceuticals | 19.87M |
| Erika Carmel-Tech | 19.48M |
| Purple Biotech | 18.58M |